Molecular characterization of patients with pathologic complete response or early failure after neoadjuvant chemotherapy for locally advanced breast cancer using next generation sequencing and nCounter assay

Neoadjuvant chemotherapy (NAC) has the added advantage of increasing breast conservation rates with equivalent survival outcomes compared with adjuvant chemotherapy. A subset of breast cancer patients who received NAC experienced early failure (EF) during the course of therapy or within a short peri...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Park, Kyunghee, Choi, Moon Ki, Jung, Hae Hyun, Do, In-Gu, Lee, Kwang Hee, Ahn, TaeJin, Kil, Won Ho, Kim, Seok Won, Lee, Jeong Eon, Nam, Seok Jin, Kim, Duk-Hwan, Ahn, Jin Seok, Im, Young-Hyuck, Park, Yeon Hee
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2015
Soggetti:
Clinical Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4695201/
https://ncbi.nlm.nih.gov/pubmed/26009992
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi